Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides - PubMed (original) (raw)
Randomized Controlled Trial
. 2008 Jun;138(6):1141-7.
doi: 10.1093/jn/138.6.1141.
Affiliations
- PMID: 18492847
- DOI: 10.1093/jn/138.6.1141
Free article
Randomized Controlled Trial
Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides
Petra A M J Scholtens et al. J Nutr. 2008 Jun.
Free article
Abstract
In this double-blind, randomized, placebo-controlled study, we investigated the effect of an infant milk formula with 6 g/L short-chain galacto- and long-chain fructo-oligosaccharides [(scGOS/lcFOS) ratio 9:1] on the development of the fecal secretory immunoglobulin A (sIgA) response and on the composition of the intestinal microbiota in 215 healthy infants during the first 26 wk of life. The infants received breast milk or were randomized to receive an infant milk formula with or without scGOS/lcFOS. Stool samples were collected after 8 and 26 wk of intervention. The concentration of fecal sIgA was determined by ELISA, and the composition of the intestinal microbiota was determined by quantitative fluorescent in situ hybridization. The scGOS/lcFOS group and the control group were compared in the statistical analysis. A breast fed group was included as a reference. In total, 187 infants completed the study. After 26 wk of intervention, in infants that were exclusively formula fed, the concentration of sIgA was higher (P < 0.001) in the scGOS/lcFOS group (719 microg/g) than in the control group (263 microg/g). In addition, the percentages of bifidobacteria were higher in the scGOS/lcFOS group (60.4%) than in the control group (52.6%, P = 0.04). The percentages of Clostridium spp. were 0.0 and 3.27%, respectively (P = 0.006). In conclusion, an infant milk formula with 6 g/L scGOS/lcFOS results in higher concentrations of fecal sIgA, suggesting a positive effect on mucosal immunity.
Similar articles
- Fermented infant formula (with Bifidobacterium breve C50 and Streptococcus thermophilus O65) with prebiotic oligosaccharides is safe and modulates the gut microbiota towards a microbiota closer to that of breastfed infants.
Béghin L, Tims S, Roelofs M, Rougé C, Oozeer R, Rakza T, Chirico G, Roeselers G, Knol J, Rozé JC, Turck D. Béghin L, et al. Clin Nutr. 2021 Mar;40(3):778-787. doi: 10.1016/j.clnu.2020.07.024. Epub 2020 Jul 23. Clin Nutr. 2021. PMID: 32893049 Clinical Trial. - Randomised controlled trial demonstrates that fermented infant formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides reduces the incidence of infantile colic.
Vandenplas Y, Ludwig T, Bouritius H, Alliet P, Forde D, Peeters S, Huet F, Hourihane J. Vandenplas Y, et al. Acta Paediatr. 2017 Jul;106(7):1150-1158. doi: 10.1111/apa.13844. Epub 2017 Apr 19. Acta Paediatr. 2017. PMID: 28328065 Free PMC article. Clinical Trial. - Effects on faecal microbiota of dietary and acidic oligosaccharides in children during partial formula feeding.
Magne F, Hachelaf W, Suau A, Boudraa G, Bouziane-Nedjadi K, Rigottier-Gois L, Touhami M, Desjeux JF, Pochart P. Magne F, et al. J Pediatr Gastroenterol Nutr. 2008 May;46(5):580-8. doi: 10.1097/MPG.0b013e318164d920. J Pediatr Gastroenterol Nutr. 2008. PMID: 18493215 Clinical Trial. - Stool characteristics of infants receiving short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides: a review.
Scholtens PA, Goossens DA, Staiano A. Scholtens PA, et al. World J Gastroenterol. 2014 Oct 7;20(37):13446-52. doi: 10.3748/wjg.v20.i37.13446. World J Gastroenterol. 2014. PMID: 25309075 Free PMC article. Review. - Oligosaccharides in infant formula: more evidence to validate the role of prebiotics.
Vandenplas Y, Zakharova I, Dmitrieva Y. Vandenplas Y, et al. Br J Nutr. 2015 May 14;113(9):1339-44. doi: 10.1017/S0007114515000823. Br J Nutr. 2015. PMID: 25989994 Review.
Cited by
- Oligosaccharides Modulate Rotavirus-Associated Dysbiosis and TLR Gene Expression in Neonatal Rats.
Azagra-Boronat I, Massot-Cladera M, Knipping K, Van't Land B, Tims S, Stahl B, Knol J, Garssen J, Franch À, Castell M, Pérez-Cano FJ, Rodríguez-Lagunas MJ. Azagra-Boronat I, et al. Cells. 2019 Aug 11;8(8):876. doi: 10.3390/cells8080876. Cells. 2019. PMID: 31405262 Free PMC article. - An Observational Real-Life Study with a New Infant Formula in Infants with Functional Gastro-Intestinal Disorders.
Vandenplas Y, Gerlier L, Caekelbergh K, Nan-Study-Group, Possner M. Vandenplas Y, et al. Nutrients. 2021 Sep 23;13(10):3336. doi: 10.3390/nu13103336. Nutrients. 2021. PMID: 34684337 Free PMC article. - Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients.
Lu H, Wu Z, Xu W, Yang J, Chen Y, Li L. Lu H, et al. Microb Ecol. 2011 Apr;61(3):693-703. doi: 10.1007/s00248-010-9801-8. Epub 2011 Feb 1. Microb Ecol. 2011. PMID: 21286703 - The use of prebiotics during the first year of life for atopy prevention and treatment.
de Moura PN, Rosário Filho NA. de Moura PN, et al. Immun Inflamm Dis. 2013 Oct;1(1):63-9. doi: 10.1002/iid3.8. Epub 2013 Oct 30. Immun Inflamm Dis. 2013. PMID: 25400918 Free PMC article. Review. - Cow's milk-based beverage consumption in 1- to 4-year-olds and allergic manifestations: an RCT.
Pontes MV, Ribeiro TC, Ribeiro H, de Mattos AP, Almeida IR, Leal VM, Cabral GN, Stolz S, Zhuang W, Scalabrin DM. Pontes MV, et al. Nutr J. 2016 Feb 27;15:19. doi: 10.1186/s12937-016-0138-0. Nutr J. 2016. PMID: 26920136 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous